Activation of B cells by CD73 blocking antibodies.

被引：0
|
作者：
Hair, James [1 ]
Garcon, Fabien [1 ]
Hsueh, Michelle [2 ]
Dallaway, Laura [1 ]
Bibikova, Elena [2 ]
Letizia, Maria
Torchia, Giardino [3 ]
Moody, Gordon [3 ]
Schuller, Alwin [4 ]
Dovedi, Simon J. [1 ]
Cooper, Zachary A. [3 ]
Sachsenmeier, Kris [4 ]
Kumar, Rakesh [3 ]
Eyles, Jim [1 ]
Wilkinson, Robert W. [1 ]
机构：
[1] AstraZeneca Ltd, Cambridge, England
[2] Acerta Pharma LLC, San Francisco, CA USA
[3] AstraZeneca Ltd, Gaithersburg, MD USA
[4] AstraZeneca Ltd, Waltham, MA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1695
引用
收藏
页数：2
相关论文
共 50 条
  • [31] CD73 as a target in cancer immunotherapy
    Smyth, Mark J.
    Beayis, Paul
    Darcy, Phil K.
    Loi, Sherene
    Stagg, John
    CANCER RESEARCH, 2012, 72
  • [32] The role of CD73 on afferent lymphatics
    Eichin, Dominik
    Laurila, Juha
    Jalkanen, Sirpa
    Salmi, Marko
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2016, 83 (05) : 359 - 360
  • [33] A possible role for LFA-1, CD39 and CD73 in regulatory T and B cells in psoriasis
    Terras, Sarah
    Mollet, Ilse
    Dullaers, Melissa
    van Geel, Nanja
    Lambert, Jo
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S14 - S14
  • [34] CD73 expression in metastatic melanoma
    Monteiro, I. de Paula Costa
    Vigano, S.
    Menetrier-Caux, C.
    Caux, C.
    Romero, P.
    de Leval, L.
    VIRCHOWS ARCHIV, 2017, 471 : S204 - S204
  • [35] MEASURING SOLUBLE CD73 ACTIVITY IN HIGH CONCENTRATIONS OF HUMAN PLASMA TO ASSESS PHARMACODYNAMICS OF CD73 INHIBITORS
    Sorensen, Rick
    Zavodovskaya, Marianna
    Yi, Ping Cheng
    Lee, Michael
    Goddard, Audrey
    Peach, Matthew
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A37 - A38
  • [36] The expression of CD73 on pathological B-cells is associated with shorter overall survival of patients with CLL
    Kicova, M.
    Michalova, Z.
    Coma, M.
    Gabzdilova, J.
    Dedinska, K.
    Guman, T.
    Bernatova, S.
    Hajikova, M.
    Giertlova, M.
    Veselinyova, D.
    Sarissky, M.
    NEOPLASMA, 2020, 67 (04) : 933 - 938
  • [37] CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells
    Katsuta, Eriko
    Tanaka, Shinji
    Mogushi, Kaoru
    Shimada, Shu
    Akiyama, Yoshimitsu
    Aihara, Arihiro
    Matsumura, Satoshi
    Mitsunori, Yusuke
    Ban, Daisuke
    Ochiai, Takanori
    Kudo, Atsushi
    Fukamachi, Hiroshi
    Tanaka, Hiroshi
    Nakayama, Koh
    Arii, Shigeki
    Tanabe, Minoru
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (02) : 657 - 669
  • [38] CD73 conjugated microspheres as targeting vehicles for mesenchymal stem cells
    Ansboro, S.
    Greiser, U.
    Hayes, J.
    Barron, V.
    Brown, S.
    Pandit, A.
    Murphy, M.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2012, 6 : 58 - 58
  • [39] CD73: A therapeutic target for pancreatic neuroendocrine tumor stem cells
    Katsuta, Eriko
    Tanaka, Shinji
    Mogushi, Kaoru
    Shimada, Shu
    Akiyama, Yoshimitsu
    Aihara, Arihiro
    Matsumura, Satoshi
    Mitsunori, Yusuke
    Ban, Daisuke
    Ochiai, Takanori
    Kudo, Atsushi
    Fulcamachi, Hiroshi
    Tanaka, Hiroshi
    Nakayama, Koh
    Arii, Shigeki
    Tanabe, Minoru
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 : S5 - S5
  • [40] DYSREGULATED BALANCE OF CD39 AND CD73 CELLS IN DIABETIC ESRD PATIENTS
    Jo, Young-Il
    Seo, Eun-Hye
    Kim, Joo-Dong
    Lee, Seung-Hyun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 173 - 173
12345